TrialThe journal of allergy and clinical immunology. In practice

Biomarkers of Type 2 Airway Inflammation as Predictors of Loss of Asthma Control During Step-Down Therapy for Well-Controlled Disease: The Long-Acting Beta-Agonist Step-Down Study (LASST).

Sonali Bose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.